What were Zim Laboratories Ltd's latest quarterly results?
Zim Laboratories Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +10.0% (turning around (inflection up))
- Revenue Growth YoY: +12.8%
- Operating Margin: 11.8% (volatile)
Zim Laboratories Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +45.3%AverageNew This Week
In , Zim Laboratories Ltd (Pharma - Formulators) is outperforming Nifty 500 with +45.3% relative strength. Fundamentals: Average.
Zim Laboratories Ltd Key Facts
- PE Ratio
- 79.0x
- Market Cap
- ₹552 Cr
- PAT Growth YoY
- +10%
- Revenue Growth YoY
- +13%
- OPM
- 11.8%
- RS vs Nifty 500
- +45.3%
PE: At PeakDanger Bubble
What's Happening
⚠️PE rising despite falling earnings — price running ahead of reality
Key Numbers
PAT Growth YoY
+10%
Inflection Up
Revenue YoY
+13%
Inflection Up
Operating Margin
11.8%
-21 bps YoY
PE Ratio
79.0
Current Price
₹103
Fundamental Score
40/100
Average
3Y PAT CAGR
-7%
Market Cap
552 Cr
Valuation
N/A12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
How Fast Is Zim Laboratories Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +13% | +4% | Inflection Up |
| PAT (Net Profit) | +10% | -7% | Inflection Up |
| OPM | 11.8% | -21 bps | Volatile |
Other Top Pharma - Formulators Stocks Beating Nifty 500
Frequently Asked Questions: Zim Laboratories Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is Zim Laboratories Ltd's profit growing or declining?
Zim Laboratories Ltd's profit is growing with an turning around (inflection up) trend.
- PAT Growth YoY: +10.0% (latest quarter)
- PAT Growth QoQ: +1147.6% (sequential)
- 3-Year PAT CAGR: -7.2%
- Trend: Turning around (inflection up) — consistent growth pattern
What is Zim Laboratories Ltd's revenue growth trend?
Zim Laboratories Ltd's revenue growth trend is turning around (inflection up).
- Revenue Growth YoY: +12.8%
- Revenue Growth QoQ: +22.5% (sequential)
- 3-Year Revenue CAGR: +4.4%
How is Zim Laboratories Ltd's operating margin trending?
Zim Laboratories Ltd's operating margin is volatile.
- Current OPM: 11.8%
- OPM Change YoY: -0.2% basis points
- OPM Change QoQ: +5.3% basis points
What is Zim Laboratories Ltd's 3-year profit and revenue CAGR?
Zim Laboratories Ltd's long-term compounding rates
- 3-Year Profit CAGR: -7.2%
- 3-Year Revenue CAGR: +4.4%
Is Zim Laboratories Ltd's growth accelerating or decelerating?
Zim Laboratories Ltd's earnings growth is turning around (inflection up) with mixed signals on a sequential basis.
- YoY Acceleration: +90.0% bps
- Sequential Acceleration: 0.0% bps
What is Zim Laboratories Ltd's trailing twelve month (TTM) performance?
Zim Laboratories Ltd's trailing twelve month (TTM) performance
- TTM PAT: ₹7 Cr
- TTM PAT Growth: -54.5% YoY
- TTM Revenue: ₹378 Cr
- TTM Revenue Growth: -2.6% YoY
- TTM Operating Margin: 9.9%
What is Zim Laboratories Ltd's current PE ratio?
Zim Laboratories Ltd's current PE ratio is 79.0x.
- Current PE: 79.0x
- Market Cap: 552 Cr
What is Zim Laboratories Ltd's price-to-book ratio?
Zim Laboratories Ltd's price-to-book ratio is 2.0x.
- Price-to-Book (P/B): 2.0x
- Book Value per Share: ₹52
- Current Price: ₹103
Is Zim Laboratories Ltd a fundamentally strong company?
Zim Laboratories Ltd is rated Average with a fundamental score of 40.2/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +12.8% (10% weight)
- PAT Growth YoY: +10.0% (10% weight)
- PAT Growth QoQ: +1147.6% (10% weight)
- Margins stable (10% weight)
Is Zim Laboratories Ltd debt free?
Zim Laboratories Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹121 Cr
What is Zim Laboratories Ltd's return on equity (ROE) and ROCE?
Zim Laboratories Ltd's return ratios over recent years
- FY2023: ROCE 17.0%
- FY2024: ROCE 10.0%
- FY2025: ROCE 8.0%
Is Zim Laboratories Ltd's cash flow positive?
Zim Laboratories Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹41 Cr
- Free Cash Flow (FCF): ₹1 Cr
- CFO/PAT Ratio: 342% (strong cash conversion)
What is Zim Laboratories Ltd's dividend yield?
Zim Laboratories Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹103
Who holds Zim Laboratories Ltd shares — promoters, FII, DII?
Zim Laboratories Ltd's shareholding pattern (Mar 2026)
- Promoters: 30.4%
- FII (Foreign): 0.0%
- DII (Domestic): 0.1%
- Public: 69.6%
Is promoter holding increasing or decreasing in Zim Laboratories Ltd?
Zim Laboratories Ltd's promoter holding has decreased recently.
- Current Promoter Holding: 30.4% (Mar 2026)
- Previous Quarter: 33.3% (Dec 2025)
- Change: -2.91% (decreasing — worth monitoring)
How long has Zim Laboratories Ltd been outperforming Nifty 500?
Zim Laboratories Ltd has been outperforming Nifty 500 for 1 consecutive week, indicating early-stage outperformance.
Is Zim Laboratories Ltd a new momentum entry or an established outperformer?
Zim Laboratories Ltd is a new entry this week — it just started outperforming Nifty 500. New entries are worth monitoring for follow-through.
Is Zim Laboratories Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Zim Laboratories Ltd may be worth studying
- Earnings growing at +10.0% YoY
- Cash flow is positive — CFO ₹41 Cr
What is the investment thesis for Zim Laboratories Ltd?
Zim Laboratories Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +12.8% YoY
What is the future outlook for Zim Laboratories Ltd?
Zim Laboratories Ltd's forward outlook based on current data signals
- Earnings Trend: turning around (inflection up)
- Revenue Trend: turning around (inflection up)
- Margin Trend: volatile
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.